GLP-1 drugs: what Healthy Louisiana paid

Q: Does a paid prescription mean Healthy Louisiana covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Healthy Louisiana shows a published payment figure for 6 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Healthy Louisiana's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Healthy Louisiana’s payment record shows

In 2026Q1, the product Healthy Louisiana paid for most often was Mounjaro®, at 20,809 prescriptions⁷ of the 39,927 to 40,125^{1,7,13,19,25,43} across all 8 products, or 52 percent of the published count.

Healthy Louisiana itself reimbursed at least $40,549,834 for these products in the quarter, about $1,016 per prescription. Pharmacies were paid $41,848,539 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,239.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Healthy Louisiana finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Healthy Louisiana. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Healthy Louisiana paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Healthy Louisiana paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Managed care	at least 470¹	1%	$468,743	$498,778	$997
tirzepatideMounjaro®	Both20,630 managed care, 179 direct	at least 20,809⁷	52%	$21,568,512	$22,391,861	$1,036
semaglutideWegovy®	Managed care	at least 771¹³	2%	$955,646	$1,016,992	$1,239
semaglutideOzempic®	Both16,740 managed care, 324 direct	at least 17,064¹⁹	43%	$16,807,981	$17,170,899	$985
semaglutideRybelsus®	Both	at least 716²⁵	2%	$724,624	$744,468	$1,012
liraglutideSaxenda®	Not published	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both	Withheld	n/a	Not published	Not published	Not published
liraglutideliraglutide (generic)	Managed care	at least 75⁴³	<1%	$24,329	$25,541	$324

Healthy Louisiana publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Against enrollment, that is 32.1 to 32.2 prescriptions per thousand people enrolled in Healthy Louisiana, on an average of 1,245,380 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 23 of the 168 product-quarters it holds a row for here, which is 14 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic® and Rybelsus® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Healthy Louisiana pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Healthy Louisiana paid for each product, quarter by quarter

Prescriptions Healthy Louisiana paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	at least 20 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld⁴At least$19,776 paid	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable³Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable²Withheld4 of 4 product codes withheld	at least 110 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$110,831 paid	at least 470 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$468,743 paid
tirzepatideMounjaro®range 18,538 to 27,189	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹¹Withheld2 of 2 product codes withheld	at least 471 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$446,700 paid	at least 2,256 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$2,157,184 paid	at least 5,587 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$5,600,197 paid	at least 9,782 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$9,800,084 paid	at least 13,177 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$13,236,589 paid	at least 15,905 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$15,747,316 paid	18,538 paid prescriptions in the quarter (2024Q1)⁹Count$19,287,725 paid	at least 16,658 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$17,190,327 paid	at least 21,764 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$21,822,169 paid	at least 23,018 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$22,602,554 paid	at least 24,300 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$24,360,809 paid	26,038 paid prescriptions in the quarter (2025Q2)⁸Count$25,531,576 paid	27,189 paid prescriptions in the quarter (2025Q3)⁸Count$27,286,498 paid	at least 25,915 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$26,036,446 paid	at least 20,809 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$21,568,512 paid
semaglutideWegovy®range 12 to 960	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2021Q2)every reporting cell was withheld, so nothing is observable¹⁸Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable¹⁶Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable¹⁶Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable¹⁶Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable¹⁶Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable¹⁵Withheld3 of 3 product codes withheld	12 paid prescriptions in the quarter (2024Q2)¹⁵Count$15,780 paid	at least 104 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld¹⁵At least$128,584 paid	196 paid prescriptions in the quarter (2024Q4)¹⁵Count$255,810 paid	at least 286 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld¹⁴At least$375,293 paid	376 paid prescriptions in the quarter (2025Q2)¹⁴Count$479,437 paid	452 paid prescriptions in the quarter (2025Q3)¹⁴Count$592,034 paid	960 paid prescriptions in the quarter (2025Q4)¹⁴Count$1,210,077 paid	at least 771 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$955,646 paid
semaglutideOzempic®range 26,405 to 36,530	at least 1,402 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$1,263,075 paid	at least 1,675 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$1,518,818 paid	at least 1,895 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$1,706,468 paid	at least 2,415 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$2,163,129 paid	at least 2,959 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$2,746,442 paid	at least 4,008 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$3,718,999 paid	at least 8,788 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$8,144,226 paid	at least 15,710 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$14,172,503 paid	at least 28,083 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$26,194,024 paid	at least 47,155 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$43,437,590 paid	at least 37,002 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$34,042,497 paid	at least 35,802 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$32,974,932 paid	36,530 paid prescriptions in the quarter (2024Q1)²¹Count$35,208,347 paid	at least 35,873 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$35,155,230 paid	at least 38,560 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$35,154,674 paid	at least 33,810 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$30,717,139 paid	at least 24,254 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$22,894,996 paid	at least 26,754 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$24,838,955 paid	26,405 paid prescriptions in the quarter (2025Q3)²⁰Count$25,026,060 paid	at least 23,650 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$22,474,994 paid	at least 17,064 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$16,807,981 paid
semaglutideRybelsus®	252 paid prescriptions in the quarter (2021Q1)³⁰Count$208,699 paid	at least 352 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$289,101 paid	at least 449 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$393,785 paid	at least 524 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$458,970 paid	at least 635 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$597,716 paid	at least 694 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$653,748 paid	at least 855 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$807,426 paid	at least 971 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$920,651 paid	at least 1,128 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$1,117,773 paid	at least 1,156 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$1,112,105 paid	at least 1,018 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$951,866 paid	at least 891 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$828,657 paid	at least 953 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$984,354 paid	at least 815 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$842,431 paid	at least 1,077 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$1,020,247 paid	at least 973 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$903,738 paid	at least 796 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$767,960 paid	at least 973 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$931,197 paid	at least 975 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$933,688 paid	at least 892 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$862,564 paid	at least 716 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$724,624 paid
liraglutideSaxenda®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter³⁵No row	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q4)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter³⁴No row	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 896 to 8,660	8,549 paid prescriptions in the quarter (2021Q1)⁴²Count$7,737,137 paid	8,660 paid prescriptions in the quarter (2021Q2)⁴²Count$8,012,457 paid	7,587 paid prescriptions in the quarter (2021Q3)⁴²Count$7,062,695 paid	6,856 paid prescriptions in the quarter (2021Q4)⁴²Count$6,475,611 paid	6,360 paid prescriptions in the quarter (2022Q1)⁴¹Count$6,249,622 paid	5,882 paid prescriptions in the quarter (2022Q2)⁴¹Count$5,846,853 paid	5,154 paid prescriptions in the quarter (2022Q3)⁴¹Count$5,160,688 paid	4,618 paid prescriptions in the quarter (2022Q4)⁴¹Count$4,595,403 paid	4,324 paid prescriptions in the quarter (2023Q1)⁴⁰Count$4,488,083 paid	3,619 paid prescriptions in the quarter (2023Q2)⁴⁰Count$3,559,252 paid	2,402 paid prescriptions in the quarter (2023Q3)⁴⁰Count$2,343,360 paid	at least 1,869 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld⁴⁰At least$1,876,288 paid	1,406 paid prescriptions in the quarter (2024Q1)³⁹Count$1,046,955 paid	896 paid prescriptions in the quarter (2024Q2)³⁹Count$633,098 paid	at least 511 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³⁹At least$323,663 paid	at least 421 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³⁹At least$276,452 paid	at least 80 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld³⁸At least$50,566 paid	at least 39 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld³⁸At least$24,355 paid	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable³⁷Withheld1 of 1 product codes withheld
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable⁴⁵Withheld1 of 1 product codes withheld	at least 379 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$196,697 paid	at least 82 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$42,143 paid	at least 218 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$110,908 paid	at least 267 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$126,662 paid	at least 275 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$129,564 paid	at least 168 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$58,150 paid	at least 75 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$24,329 paid

What this page cannot tell you

Whether Healthy Louisiana covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Louisiana in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, LA
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state LA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "LA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "263"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, LA
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state LA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "69"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, LA
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state LA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, LA
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state LA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "20"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, LA
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state LA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "product_name": "product_name like ZEPBOUND%, state LA, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, LA
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state LA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "product_name": "product_name like ZEPBOUND%, state LA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, LA
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state LA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "LA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "4373"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, LA
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state LA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "6048"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, LA
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state LA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "5980"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, LA
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state LA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "4824"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, LA
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state LA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "1028"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, LA
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state LA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "product_name": "product_name like MOUNJARO%, state LA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, LA
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state LA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "LA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "209"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, LA
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state LA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "369"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, LA
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state LA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "73"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, LA
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state LA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, LA
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state LA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "product_name": "product_name like WEGOVY%, state LA, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, LA
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state LA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2021", "quarter": "2", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, LA
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state LA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "LA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "5828"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, LA
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state LA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "9052"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, LA
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state LA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "15064"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, LA
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state LA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "22790"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, LA
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state LA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "9031"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, LA
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state LA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1195"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, LA
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state LA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "LA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "264"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, LA
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state LA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "389"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, LA
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state LA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "463"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, LA
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state LA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "519"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, LA
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state LA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "424"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, LA
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state LA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "209"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, LA
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state LA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "LA", "product_name": "product_name like SAXENDA%, state LA, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, LA
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state LA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, LA
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state LA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, LA
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state LA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, LA
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state LA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, LA
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state LA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "product_name": "product_name like SAXENDA%, state LA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, LA
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state LA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "LA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, LA
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state LA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "52"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, LA
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state LA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "748"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, LA
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state LA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "2334"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, LA
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state LA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "3447"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, LA
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state LA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2021", "quarter": "2", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "4577"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, LA
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state LA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "LA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "26"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, LA
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state LA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "89"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, LA
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state LA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "225"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, LA
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state LA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "product_name": "product_name like LIRAGLUTID%, state LA, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, LA
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state LA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "product_name": "product_name like LIRAGLUTID%, state LA, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, LA
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state LA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "LA", "product_name": "product_name like LIRAGLUTID%, state LA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 39 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 9 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Healthy Louisiana covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.